ISRCTN84092396已完成不适用
T-cell Inhibition by Mycophenolate Mofetil Treatment in Patients Undergoing Carotid Endarterectomy
Academic Medical Center (AMC) (The Netherlands)0 个研究点目标入组 50 人开始时间: 2007年1月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Consecutive patients with carotid artery stenosis (more than 70% diameter stenosis on angiography or ultrasonography) with ipsilateral Transient Ischaemic Attack (TIA) who are planned to undergo Carotid EndArterectomy (CEA) will be included and treated for a minimum of three weeks prior to surgery. These patients will be recruited at the outpatient department of Vascular Surgery.
排除标准
- •Patients who are unable to tolerate MMF treatment, who withdraw their consent or those with any other medical condition or laboratory abnormality which in the opinion of the principal investigator could affect subject safety, preclude evaluation of response, or render unlikely that the patient would complete the study, are excluded.
研究者
相似试验
招募中
不适用
T-cell Inhibition by Mycophenolate Mofetil Treatment in Patients Undergoing Carotid Endarterectomy.Atherosclerotic vascular disease of the carotid arteryNL-OMON21023Academic Medical CenterAmsterdam, the Netherlands50
进行中（未招募）
1 期
Influence of mycophenolate mofetil (Cellcept) on the progression of diabetic nephropathyDiabetes mellitus Type 2 with microalbuminuriaEUCTR2008-003768-20-ATMedizinische Universität Wien, Universitätsklinik f. Innere Med. III, Abt. f. Nephrologie u. Dialyse
招募中
2 期
The effect of mycophenolate mofetil in controlling the recurrence of idiopathic nephrotic syndrome in steroid-dependent children or frequent recurrenceephrotic syndrome.Nephrotic syndromeIRCT20130812014333N113Kermanshah University of Medical Sciences12
已完成
不适用
Mycophenolate mofetil treatment in a patient with frequently relapsing nephrotic syndromefrequently relapsing nephrotic syndromeJPRN-UMIN000007511Kumamoto University, Faculty of Life Sciences, Department of Pediatrics1
终止
3 期
Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)CancerNCT00089141Martin, Paul151